ESC 365 - SCD Risk Stratification: Which Patient Benefits from the Wearable Cardioverter Defibrillator?

Open Access

SCD Risk Stratification: Which Patient Benefits from the Wearable Cardioverter Defibrillator?

Session: The Wearable Cardioverter Defibrillator (WCD): Clinical Update and Future Directions for the Management of Patients with Ventricular Arrhythmias

Topic: Prevention

Speaker: Doctor M. Biffi (Bologna, IT)

Sponsored by ZOLL

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Mauro Biffi

S. Orsola-Malpighi Policlinic, Bologna (Italy)

39 presentations

2 followers

5 more presentations in this session

Introduction.

The Power of Per-Protocol Analyses: What Have We Learned from the VEST-Trial?

Speaker: Professor S. Boveda (Toulouse, FR)

Predictors of Sudden Cardiac Death: What Role Does the Heart Rate Play?

Speaker: Professor J. Sperzel (Bad Nauheim, DE)

Heart Failure Patient Management: Improved Outcomes for WCD Patients?

Speaker: Professor D. Bondermann (Vienna, AT)

Discussion and Summary.

Speaker: Professor C. Leclercq (Rennes, FR)

Access the full session

The Wearable Cardioverter Defibrillator (WCD): Clinical Update and Future Directions for the Management of Patients with Ventricular Arrhythmias

Speakers: Doctor M. Biffi, Professor S. Boveda, Professor J. Sperzel, Professor D. Bondermann, Professor C. Leclercq

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources